JP5074184B2 - 目の画像品質の改良 - Google Patents

目の画像品質の改良 Download PDF

Info

Publication number
JP5074184B2
JP5074184B2 JP2007519638A JP2007519638A JP5074184B2 JP 5074184 B2 JP5074184 B2 JP 5074184B2 JP 2007519638 A JP2007519638 A JP 2007519638A JP 2007519638 A JP2007519638 A JP 2007519638A JP 5074184 B2 JP5074184 B2 JP 5074184B2
Authority
JP
Japan
Prior art keywords
zeaxanthin
lutein
image quality
human eye
higher order
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007519638A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008505137A (ja
JP2008505137A5 (enExample
Inventor
ジョン バーバー，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of JP2008505137A publication Critical patent/JP2008505137A/ja
Publication of JP2008505137A5 publication Critical patent/JP2008505137A5/ja
Application granted granted Critical
Publication of JP5074184B2 publication Critical patent/JP5074184B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Eye Examination Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
JP2007519638A 2004-06-29 2005-06-08 目の画像品質の改良 Expired - Fee Related JP5074184B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04015189.6 2004-06-29
EP04015189 2004-06-29
PCT/EP2005/006168 WO2006002735A1 (en) 2004-06-29 2005-06-08 Improvement of image quality in the eye

Publications (3)

Publication Number Publication Date
JP2008505137A JP2008505137A (ja) 2008-02-21
JP2008505137A5 JP2008505137A5 (enExample) 2012-09-06
JP5074184B2 true JP5074184B2 (ja) 2012-11-14

Family

ID=35782481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007519638A Expired - Fee Related JP5074184B2 (ja) 2004-06-29 2005-06-08 目の画像品質の改良

Country Status (9)

Country Link
US (2) US20080045605A1 (enExample)
EP (1) EP1761254B1 (enExample)
JP (1) JP5074184B2 (enExample)
KR (1) KR20070027649A (enExample)
CN (1) CN101094666B (enExample)
AT (1) ATE441406T1 (enExample)
DE (1) DE602005016405D1 (enExample)
ES (1) ES2331083T3 (enExample)
WO (1) WO2006002735A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006084687A1 (en) * 2005-02-11 2006-08-17 Dsm Ip Assets B.V. Use of zeaxanthin for the treatment of diseases of the peripheral retina
AT503329A1 (de) * 2006-03-02 2007-09-15 Omnica Gmbh Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218436B1 (en) * 1993-06-28 2001-04-17 The Howard Foundation Pharmaceutically active carotenoids
US5382714A (en) * 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5827652A (en) * 1995-10-31 1998-10-27 Applied Food Biotechnology, Inc. Zeaxanthin formulations for human ingestion
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
WO1997048388A1 (en) * 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
US6075058A (en) * 1998-12-12 2000-06-13 Tufts University Compositions for increased bioavailability of carotenoids
US6712466B2 (en) * 2001-10-25 2004-03-30 Ophthonix, Inc. Eyeglass manufacturing method using variable index layer
ES2299687T3 (es) * 2002-01-30 2008-06-01 Dsm Ip Assets B.V. Luteina/zeaxantina para la proteccion contra el encandilamiento.
CN1481804A (zh) * 2002-12-17 2004-03-17 无锡杰西医药科技有限公司 防治白内障、黄斑变性等眼病的配方及其使用方法

Also Published As

Publication number Publication date
CN101094666A (zh) 2007-12-26
JP2008505137A (ja) 2008-02-21
ATE441406T1 (de) 2009-09-15
EP1761254A1 (en) 2007-03-14
US20080045605A1 (en) 2008-02-21
CN101094666B (zh) 2010-09-29
WO2006002735A1 (en) 2006-01-12
KR20070027649A (ko) 2007-03-09
EP1761254B1 (en) 2009-09-02
DE602005016405D1 (de) 2009-10-15
ES2331083T3 (es) 2009-12-21
US20110172313A1 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
US8071143B2 (en) Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
TR201910056T4 (tr) Göz sağlığına yönelik bileşim.
MX2012009471A (es) Composicion que comprende como ingrediente activo l-carnitina en combinacion con hidroxiquinurenina-o-beta-dl-glucosido, para la prevencion y/o tratamiento de patologias del ojo debido a radiacion ultravioleta.
US7691420B2 (en) Compositions for the treatment and prevention of diabetes mellitus
KR20230170963A (ko) 근시 치료용 방법과 약학 조성물
JP5074184B2 (ja) 目の画像品質の改良
JP5848042B2 (ja) 眼疲労抑制組成物及びそれを含む飲食品
JPWO2002094253A1 (ja) 眼の調節機能障害改善剤
ES2993253T3 (en) Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters
US9918947B2 (en) Composition of olivetol and method of use to reduce or inhibit the effects of tetrahydrocannabinol in the human body
JP7005043B2 (ja) 網膜保護組成物
CN101115476A (zh) 玉米黄质用于治疗周边视网膜疾病的用途
US12076358B2 (en) Composition of desmodium and trivalent chromium, and ocular use
MX2010013439A (es) Compuestos utiles para la prevencion o tratamiento de astenopia acomodativa.
Figurska The role of resveratrol in inhibiting the development and progression of oxidative stress-induced retinal diseases
HK40068445A (en) Composition of a dietary supplement and/or a nutritional additive for food, a unitary dosage form of said composition, and their use for improvement of the quality of visual performance including contrast sensitivity in persons in need of such an improvement, including persons suffering from at least one eye disease, particularly vitreous floaters

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110712

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111012

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111114

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120321

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120621

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120628

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120723

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120814

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120823

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150831

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees